Table 1: Newly Registered Securities | |||||||||||||||||||||||
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum aggregate offering price | Fee Rate | Amount of registration fee | ||||||||||||||||
Equity | Common stock, par value $0.001 per share: | 457(c) and 457(h) | 161,368 (2) | $1.47 (3) | $237,211 (3) | 0.00011020 | $26.14(3) | ||||||||||||||||
Total Offering Amounts | $237,211 | $26.14 | |||||||||||||||||||||
Total Fee Offsets | $0.00 | ||||||||||||||||||||||
Net Fee Due | $26.14 |
(1) | This Registration Statement covers shares of common stock, $0.001 par value per share, of Ekso Bionics Holdings, Inc., or the Registrant, that may be issued to the Ekso Bionics 401(k) Plan, or the 401(k) Plan, or its beneficiaries, as employer matching contributions. In addition, pursuant to Rule 416(c) under the Securities Act of 1933, as amended, or the Securities Act, this Registration Statement also covers an indeterminate amount of plan interests in the 401(k) Plan. | |||||||
(2) | This Registration Statement registers 161,368 shares of common stock for issuance to the 401(k) Plan, or its beneficiaries, as employer matching contributions. In accordance with Rule 416 under the Securities Act, this Registration Statement shall be deemed to cover an indeterminate number of additional shares of common stock, as may be issuable pursuant to future stock dividends, stock splits, or similar transactions. | |||||||
(3) | Estimated in accordance with Rules 457(c) and 457(h) of the Securities Act solely for the purpose of calculating the registration fee on the basis of $1.47 per share, which is the average of the high and low prices of the Registrant’s common stock as reported on the Nasdaq Capital Market on March 24, 2023. |